SBH serves an array of business and science communities in the field of developmental and reproductive toxicology
SBH serves the pharmaceutical, chemical and food industries and preclinical contract research organizations (CROs), as well as academic institutions and law firms in the field of developmental and reproductive toxicology.
Each year in the United States over 150,000 babies are born with serious, structural birth defects that are the leading cause of infant death within the first year of life.
Each year globally, pharmaceutical, chemical and food companies and universities are engaged in rigorous research and development programs to try to reduce this number.
For over 40 years, Dr. Stephen B. Harris and his network of professional resources has helped attempt to achieve this goal.
Dr. Harris combines his ability as a professional in the field of developmental and reproductive toxicology with an insightful understanding of the business of conducting scientific investigations at all levels of laboratory operations.